Key result
Microalbuminuria was significantly associated with hypertensive retinopathy (RR 0.48, p<0.0001), but not with cerebrovascular, cardiovascular, or lipid derangements in non-diabetic hypertensive patients.
Why the study?
Does microalbuminuria correlate with target organ damage in non-diabetic hypertensive patients?
Cross-Sectional (n=200)
No
Does microalbuminuria correlate with target organ damage in non-diabetic hypertensive patients?
In non-diabetic hypertensive patients, microalbuminuria is significantly associated with hypertensive retinopathy but not with other forms of target organ damage, suggesting it may be an overrated indicator for generalized target organ damage.
Answers are grounded in this paper and cite their sources.
Microalbuminuria should not yet prompt broad target organ damage screening in non-diabetic hypertension; leaves open its retinopathy-specific prognostic value in prospective cohorts.
Background: Hypertension is one of the leading causes of global burden of disease. Uncontrolled hypertension is associated with long term risk of damage to vital organs like brain, heart, kidney, blood vessels and eye i.e. Target Organ Damage (TOD). Medical scientists all over the world have been in search for an indicator which can accurately predict TOD. It is accepted that Microalbuminuria (MA) represents a more generalised vascular problem, not only confined to renal microcirculation. MA is found in a significant proportion of non-diabetic population, particularly in association with hypertension and is a predictor of cardiovascular disease. The objective of the study was to evaluate MA in hypertension and its correlation with TOD. Methods: A Hospital based cross sectional study carried out in the department medicine of central referral hospital, a well-equipped tertiary care hospital in East Sikkim, Gangtok. 200 patients were recruited fulfilling the inclusion criteria of pre hypertension, stage 1 & 2 hypertension as defined by JNC 7 report. Patients with secondary hypertension, DM, ESRD & hyperuricemia were excluded. MA was estimated by Immunoturbidimetry. Results: MA is associated with all TOD but significant correlation was found only with retinopathy. Out of 200 study subjects, 90 (45%) subjects had retinopathy out of which 54 (60%) had MA and 36 (40%) did not have MA. (P <0.0001) Conclusion: MA has established its position in DM where it indicates early end organ damage and heralds cardiovascular risk. Its role as a reliable indicator of TOD in non-diabetic hypertensives needs further evaluation.
No takes yet. Share an insight, caveat, or question.
Khandelwal et al. (2014) conducted a cross-sectional in Hypertension (n=200). Microalbuminuria vs. Normoalbuminuria (MA <30 mg/l) was evaluated on Retinopathy (RR 0.48, 95% CI 0.33-0.70, p=<0.0001). Microalbuminuria was significantly associated with hypertensive retinopathy (RR 0.48, p<0.0001), but not with cerebrovascular, cardiovascular, or lipid derangements in non-diabetic hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: